The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 

 

This Article
-Full Text
NEJM -- Farb A and Boam AB. Stent Thrombosis Redux -- The FDA Perspective. 356(10):984-7. Supplementary Audio

Interview with Donald Baim and Steven Nissen on the risks and benefits of drug-eluting stents.

photograph of Donald Baim
Donald Baim


 

Supplement to: Farb A and Boam AB. Stent Thrombosis Redux — The FDA Perspective. N Engl J Med 2007;356(10):984-7. DOI: 10.1056/NEJMp068304.

Dr. Donald Baim is chief medical and scientific officer of Boston Scientific. Dr. Steven Nissen is chairman of the Department of Cardiovascular Medicine at the Cleveland Clinic.

Rachel Gotbaum, the interviewer, is an independent producer based in Boston.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.